BRENDA WILSON: Open Payments
NPI 1407471402 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,122 in 53 payments from 15 companies in 2025. Trend: 2023 $129 · 2024 $170 · 2025 $3,122
Food & beverage: $1,655Travel & lodging: $1,467
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 13 | $1,472 |
| Medtronic, Inc. | 12 | $1,168 |
| ABBVIE INC. | 11 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Lilly USA, LLC | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: WATCHMAN, CDS broad portfolio offering, LINZESS, RINVOQ, OMVOH, XIFAXAN, WATCHMAN FLX, DUPIXENT.
Industry payments across OK — which companies pay providers there.
